Quick test in your doctor's office could fight serious lung infections
NCT ID NCT07159230
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests whether a rapid PCR test done right in the clinic can help doctors diagnose and treat acute respiratory infections faster. Over 16,000 adults at risk of severe illness will take part. The goal is to see if this approach lowers rates of respiratory failure and hospitalization.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- point-of-care multiplex PCR test
- What this could lead to
- If successful, this test could help doctors quickly identify the cause of respiratory infections and give the right treatment sooner, potentially reducing hospitalizations and severe illness.
- What could go wrong
- This is a large trial but still early in real-world use. The test may not always be accurate or change outcomes significantly, and results depend on how well clinics follow the guidance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 16,868 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2025
An estimate. Start dates often move.
- Expected to finish
-
Jan 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Onset time\<=7 days; 2. First visit; 3. Age\>=18 years old; 4. Patients with acute upper respiratory tract infection with severe high-risk factors, or patients with acute lower respiratory tract infection; 5. The condition is allowed to be treated in an outpatient clinic; 6. Signed informed consent. Exclusion Criteria: 1. The doctor judges that the disease is serious and requires hospitalization; 2. New unclear consciousness; 3. Respiratory rate\>=30 beats/min; 4. Hypoxemia or respiratory failure; 5. Heart rate\> 125 beats/min; 6. Systolic blood pressure \< 90 or diastolic blood pressure \< 60 mmHg; 7. Known active tuberculosis; 8. Pregnant and lactating women; 9. Have participated in this study within 90 days;
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute respiratory tract infection are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Xincheng District Hospital, Hohhot; Genghis Khan Community Health Service Center; East Street & West Street Sub-district Community Health Service Center; East Yingxin Road Community Health Service Center and so on
Hohhot, Inner Mongolia, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.